Literature DB >> 7083737

Caffeine disposition after oral doses.

M Bonati, R Latini, F Galletti, J F Young, G Tognoni, S Garattini.   

Abstract

Caffeine (TMX) disposition was studied in mean after 1, 5, and 10 mg/kg in water, as mocha coffee (1.54 mg/kg) and as a soft drink (0.22 mg/kg). TMX and its metabolites were analyzed in plasma and urine by high-pressure liquid chromatography. The design permitted confirmation of most of the partial results in various experimental settings and contributed new data on the metabolic disposition of TMX, with specific reference to main dimethylxanthine metabolite found in plasma, paraxanthine (1,7-dimethylxanthine). Different analysis methods were compared for the calculated parameters (absorption and elimination rate constants and renal clearance)to assess the consistency of results. The kinetics of TMX and of its dimethylated metabolites in plasma were described with a model that used an analogdigital hybrid computing system. In addition to providing a comprehensive profile of TMS disposition in the healthy adult, the results indicate tha TMX exhibits dose-independent kinetics at the levels at which man normally takes TMX.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7083737     DOI: 10.1038/clpt.1982.132

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  59 in total

Review 1.  Caffeine and endurance performance.

Authors:  M A Tarnopolsky
Journal:  Sports Med       Date:  1994-08       Impact factor: 11.136

2.  Effects of moderate exercise on the pharmacokinetics of caffeine.

Authors:  K Collomp; F Anselme; M Audran; J P Gay; J L Chanal; C Prefaut
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Adolescent caffeine consumption increases adulthood anxiety-related behavior and modifies neuroendocrine signaling.

Authors:  Casey E O'Neill; Ryan J Newsom; Jacob Stafford; Talia Scott; Solana Archuleta; Sophia C Levis; Robert L Spencer; Serge Campeau; Ryan K Bachtell
Journal:  Psychoneuroendocrinology       Date:  2016-02-01       Impact factor: 4.905

4.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.

Authors:  M A Butler; M Iwasaki; F P Guengerich; F F Kadlubar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Rapid and sensitive gas-chromatographic determination of caffeine in blood plasma, saliva, and xanthine beverages.

Authors:  H W Teeuwen; E L Elbers; J M van Rossum
Journal:  Mol Biol Rep       Date:  1991-02       Impact factor: 2.316

6.  Separate and combined effects of the social drugs on psychomotor performance.

Authors:  J S Kerr; N Sherwood; I Hindmarch
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Caffeine reversal of sleep deprivation effects on alertness and mood.

Authors:  D Penetar; U McCann; D Thorne; G Kamimori; C Galinski; H Sing; M Thomas; G Belenky
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Effects of adolescent caffeine consumption on cocaine self-administration and reinstatement of cocaine seeking.

Authors:  Tracey A Larson; Casey E O'Neill; Michaela P Palumbo; Ryan K Bachtell
Journal:  J Psychopharmacol       Date:  2018-11-28       Impact factor: 4.153

Review 9.  Recent advances in caffeine and theobromine toxicities: a review.

Authors:  M U Eteng; E U Eyong; E O Akpanyung; M A Agiang; C Y Aremu
Journal:  Plant Foods Hum Nutr       Date:  1997       Impact factor: 3.921

10.  Caffeine and paraxanthine pharmacokinetics in the rabbit: concentration and product inhibition effects.

Authors:  S H Dorrbecker; R A Ferraina; B R Dorrbecker; P A Kramer
Journal:  J Pharmacokinet Biopharm       Date:  1987-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.